EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Stem Cells To Cure Sickle Cell Anemia

Tolulope O. Rosanwo

Harvard Medical Student Review · 2020

DOI: 10.65539/056mjw33 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Harvard Medical Student Review, 2020. Verfasst von Tolulope O. Rosanwo. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sickle cell anemia (SCA) is one of the most prevalent genetic disorders in the world and the most common congenital anemia in the United States. The severity of SCA spans from mild clinical cases, managed by careful living, to severe cases involving bone crises, infection, stroke, and multi-organ failure. Hematopoietic stem cell transplantation (HSCT) is the most widely known and effective method to cure the disease and is used today in only severe cases due to risks of graft rejection and fatal infections. The use of stem cells for the cure of sickle cell disease from the early days of transplantation to the most recent breakthroughs in stem cell therapy, gene therapy and genome-editing will be examined in this review.

Zitieren

APA

Rosanwo, T. O. (2020). Stem Cells To Cure Sickle Cell Anemia. Harvard Medical Student Review. https://doi.org/10.65539/056mjw33

Vancouver

Rosanwo TO. Stem Cells To Cure Sickle Cell Anemia. Harvard Medical Student Review. 2020. doi:10.65539/056mjw33

BibTeX
@article{Rosanwo2020,
  author = {Rosanwo, Tolulope O.},
  title = {Stem Cells To Cure Sickle Cell Anemia},
  journal = {Harvard Medical Student Review},
  year = {2020},
  doi = {10.65539/056mjw33}
}
Kostenlos starten →